Lipella receives Nasdaq delisting notice; equity $1.7M vs $2.5M minimum

LIPELLA PHARMACEUTICALS INC.

Nasdaq notified Lipella on Aug 21, 2024 of non-compliance with $2.5M minimum stockholders' equity requirement.
Company reported stockholders' equity of $1,703,798 in Q2 10-Q, below the $2.5M threshold.
Company must submit compliance plan by Oct 7, 2024; intends to do so.
If plan accepted, Nasdaq may grant up to 180-day extension from Aug 21, 2024.
Failure to regain compliance could result in delisting of LIPO common stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.